STOCK PURCHASE AGREEMENT dated as of September 17, 1999, between Alta Embarcadero Biopharma Partners, LLC (the "Seller") ------ and BXA Acquisition Company, a Delaware corporation ("Purchaser"). --------- Seller understands that Purchaser is...Stock Purchase Agreement • September 24th, 1999 • Diatide Inc • In vitro & in vivo diagnostic substances • New York
1 EXHIBIT 10.2 FORM OF COMMON STOCK PURCHASE WARRANT GRANTED TO INVESTORS THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTDiatide Inc • October 1st, 1997 • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 10.2 ------------ REGISTRATION RIGHTS AGREEMENT ----------------------------- This Agreement dated as of January 19, 1999 is entered into by and among Diatide, Inc., a Delaware corporation (the "Company"), and the Stockholders identified on...Registration Rights Agreement • January 25th, 1999 • Diatide Inc • In vitro & in vivo diagnostic substances • Delaware
1 EXHIBIT 10.1 REGISTRATION RIGHTS AGREEMENT This Agreement dated as of September 23, 1997 is entered into by and among Diatide, Inc., a Delaware corporation (the "Company"), and the Stockholders identified on Schedule I hereto (the "Stockholders")....Registration Rights Agreement • October 1st, 1997 • Diatide Inc • In vitro & in vivo diagnostic substances • Delaware
STOCK PURCHASE AGREEMENT dated as of September 17, 1999, between Chase Venture Capital Associates, L.P. (the "Seller") and ------ BXA Acquisition Company, a Delaware corporation ("Purchaser"). --------- Seller understands that Purchaser is...Stock Purchase Agreement • September 24th, 1999 • Diatide Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT (c)(1) AGREEMENT AND PLAN OF MERGER Dated as of September 17, 1999,Agreement and Plan of Merger • September 24th, 1999 • Diatide Inc • In vitro & in vivo diagnostic substances • Delaware
DIATIDE, INC. -------------Diatide Inc • January 25th, 1999 • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.25 January 1, 1998 Richard T. Dean, Ph.D. President and CEO Diatide, Inc. 9 Delta Drive Londonderry, NH 03053 Re: Consulting Agreement Dear Richard: This letter agreement is to set forth the terms under which Healthcare Technology Group...Diatide Inc • March 30th, 1998 • In vitro & in vivo diagnostic substances • Arizona
